Publication search

Metabolic interactions between cysteamine and epigallocatechin gallate.

Published in Cell cycle (Georgetown, Tex.)

Phase II clinical trials indicate that the combination of cysteamine plus epigallocatechin gallate (EGCG) is effective against cystic fibrosis in patients bearing the most frequent etiological mutation (CFTRΔF508). Here, we investigated the interaction between both agents on cultured respiratory epithelia cells from normal and CFTRΔF508-mutated don...

Metabolic interactions between cysteamine and epigallocatechin gallate

Published in Cell Cycle

Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells

Published in Cell Cycle

SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors

Published in Cell Cycle

The oncolytic peptide LTX-315 triggers necrotic cell death

Published in Cell Cycle

Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo

Published in Cell Cycle

Fitting WWP-1 in the dietary restriction network.

Published in Cell cycle (Georgetown, Tex.)

Sirt3 prevents maternal obesity-associated oxidative stress and meiotic defects in mouse oocytes

Published in Cell Cycle

Metabolic epistasis among apoptosis-inducing factor and the mitochondrial import factor CHCHD4

Published in Cell Cycle

The oncolytic peptide LTX-315 triggers necrotic cell death.

Published in Cell cycle (Georgetown, Tex.)

The oncolytic peptide LTX-315 has been designed for killing human cancer cells and turned out to stimulate anti-cancer immune responses when locally injected into tumors established in immunocompetent mice. Here, we investigated the question whether LTX-315 induces apoptosis or necrosis. Transmission electron microscopy or morphometric analysis of ...